A 10-week Efficacy Study of NOE-105 in Childhood Onset Fluency Disorder
Status:
Recruiting
Trial end date:
2023-10-31
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the effectiveness of NOE-105 on speech fluency without the
known antipsychotic-induced side effects of commonly used treatments for childhood onset
fluency disorder (COFD).